Objective response rate (n, %) | Disease control rate (n, %) | |
---|---|---|
Baseline blood NLR | ||
> 2.9 (n = 14) | 1 (7.1) | 5 (35.7) |
≤ 2.9 (n = 10) | 3 (30) | 6 (60.0) |
Baseline serum Na | ||
< 135 mmol/L (n = 4) | 0 (0.0) | 1 (25.0) |
≥ 135 mmol/L (n = 20) | 4 (20.0) | 10 (50.0) |
Tumor PD-L1 | ||
CPS < 1% (n = 10) | 1 (10.0) | 2 (20.0) |
CPS ≥ 1% (n = 8) | 3 (37.5) | 7 (87.5) |
CPS ≥ 10% (n = 2) | 1 (50.0) | 2 (100.0) |
Tumor EBV | ||
Negative (n = 13) | 3 (23.1) | 6 (46.2) |
Positive (n = 5) | 1 (20.0) | 3 (60.0) |
Tumor mutation burden | ||
≤ 8.2/Mb (n = 6) | 1 (16.7) | 3 (50.0) |
> 8.2/Mb (n = 6) | 2 (33.3) | 3 (50.0) |